Gain Access to exclusive preclinical content.
Complete the form below to gain access to mattis aliquet nunc aliquam tempor. We’ll assign a user name and password, then send you a link. Thanks!

Get Access Register

EXCLUSIVE PRECLINICAL CONTENT.
You must log in to access content on this page. Or click here to request access.
The elevation of circulating fibroblast growth factor 23 without kidney disease does not increase cardiovascular disease risk

Eva-Maria Pastor-Arroyo, Nicole Gehring, Christiane Krudewig, Sarah Costantino, Carla Bettoni, Thomas Knöpfel, Sibylle Sabrautzki, Bettina Lorenz-Depiereux, Johanne Pastor, Tim M. Strom, Martin Hrabě de Angelis, Giovanni G. Camici, Francesco Paneni, Carsten A. Wagner, Isabel Rubio-Aliaga, “The elevation of circulating fibroblast growth factor 23 without kidney disease does not increase cardiovascular disease risk,” Kidney Int. 2018 Jul;94(1):49-59. doi: 10.1016/j.kint.2018.02.017. Epub 2018 May 5.